Results 281 to 290 of about 158,005 (297)
Some of the next articles are maybe not open access.

Baseline Low-Density Lipoprotein Cholesterol Is an Important Predictor of the Benefit of Intensive Lipid-Lowering Therapy

Journal of the American College of Cardiology, 2008
Roberto R Giraldéz   +2 more
exaly  

Economic Evaluation of Lipid-Lowering Therapy in the Secondary Prevention Setting in the Philippines

Value in Health Regional Issues, 2013
Bernadette A Tumanan-Mendoza
exaly  

Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease

Journal of the American College of Cardiology, 2015
Vera Bittner, Luqin Deng
exaly  

In-Hospital Initiation of Lipid-Lowering Therapy

Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 2004
openaire   +2 more sources

Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy

Journal of Clinical Pharmacy and Therapeutics, 2004
G M Peterson, Mark Naunton, J H Vial
exaly  

[Lipid-lowering therapy in the elderly].

Revue medicale de Bruxelles
During the last decade, life expectancy increased in western countries. Among the elderly, cardiovascular diseases are still the leading cause of death. In both genders, cardiovascular risk increases with age. The statistical correlation between total cholesterol level and mortality is less substantial with age, yet it still exists.
openaire   +1 more source

Impact of Lipid-Lowering Therapy on Mortality According to the Baseline Non-HDL Cholesterol Level: A Meta-Analysis

High Blood Pressure and Cardiovascular Prevention, 2019
Walter Masson   +2 more
exaly  

Home - About - Disclaimer - Privacy